MediciNova (MNOV) Revenue & Revenue Breakdown
MediciNova Revenue Highlights
Latest Revenue (Y)
$1.00M
Latest Revenue (Q)
$123.32M
MediciNova Revenue by Period
MediciNova Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.00M | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2021-12-31 | $4.04M | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | -100.00% |
| 2013-12-31 | $6.00M | 647.99% |
| 2012-12-31 | $802.58K | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | -100.00% |
| 2007-12-31 | $263.88M | 99900.00% |
| 2006-12-31 | $263.88K | -67.18% |
| 2005-12-31 | $804.07K | 64.00% |
| 2004-12-31 | $490.28K | 100.00% |
| 2003-12-31 | - | 100.00% |
| 2002-12-31 | - | 100.00% |
| 2001-12-31 | - | - |
MediciNova generated $1.00M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
MediciNova Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $123.32M | 91519.55% |
| 2025-06-30 | $134.60K | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $-999.77M | -199.98% |
| 2023-09-30 | $1.00B | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $4.03B | 10755800.00% |
| 2021-09-30 | $37.50K | 100.00% |
| 2021-06-30 | - | -100.00% |
| 2021-03-31 | $4.00M | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | -100.00% |
| 2013-12-31 | $6.00M | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | -100.00% |
| 2013-03-31 | $3.26K | -90.42% |
| 2012-12-31 | $34.00K | -59.43% |
| 2012-09-30 | $83.79K | -83.03% |
| 2012-06-30 | $493.62K | 158.21% |
| 2012-03-31 | $191.17K | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | 100.00% |
| 2007-12-31 | - | - |
MediciNova generated $123.32M in revenue during Q3 2025, up 91519.55% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
MediciNova Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| FBIO | Fortress Biotech | $55.13M | $17.02M |
| VXRT | Vaxart | $28.70M | $39.73M |
| CBUS | Cibus | $4.26M | $933.00K |
| TCRX | TScan Therapeutics | $2.82M | - |
| MNOV | MediciNova | $1.00M | $123.32M |
| RLMD | Relmada Therapeutics | - | - |
| XBIT | XBiotech | - | - |
| BMEA | Biomea Fusion | - | - |
| ACRV | Acrivon Therapeutics | - | - |
| PMVP | PMV Pharmaceuticals | - | - |
| IMUX | Immunic | - | - |